Yu Yong sold $27K of GNLX

Yu Yong (Chief Scientific Officer) sold 9,683 shares of GENELUX Corp (GNLX) at $2.75 on 2026-08-31.

Original reporting
SEC EDGAR · Yu Yong
Published Sep 2, 2026, 11:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 11:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GNLX
Neutral
high confidence
Mentioned
$GNLX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GNLXNeutralLow
01

Why it matters

The disclosed sale is unlikely to affect GNLX's stock price materially.

02

Market read

Limited relevance; serves as a routine disclosure for compliance tracking.

03

What to watch

Potential future insider transactions or broader ownership changes.

Relevance 3/10Novelty 2/10Timing: post-market filing

Background

Form 4 filings disclose insider transactions; small sales are routine and often not market moving.

Company-level read

Ticker impact

$GNLXNeutralHigh confidence
Context

Chief Scientific Officer Yu Yong sold 9,683 shares of GENELUX Corp for $26,658, a routine insider sale disclosed via Form 4.

Expected impact

No significant move expected.

Evidence & confidence

The sale amount is small relative to holdings and market cap; no broader implications.

Market effects

None

None

None

Counterpoint

The sale could signal insider concern, but size is too small to act on.

Key entities

  • GENELUX Corp

    Biotech company listed under ticker GNLX.

  • Yu Yong

    Chief Scientific Officer of GENELUX Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles